Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study

Wen Zhang,1,* Yong Li,2,* Liyan Xue,3 Dong Qu,4 Zhichao Jiang,1 Zhen Wang,2 Zhaoyang Yang,3 Aiping Zhou1 1Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Zhang W, Li Y, Xue L, Qu D, Jiang Z, Wang Z, Yang Z, Zhou A
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Dove Medical Press 2021-03-01
Serie:	Cancer Management and Research
Soggetti:	albumin-bound paclitaxel cisplatin capecitabine esophageal squamous cell carcinoma neoadjuvant chemotherapy pathological complete response
Accesso online:	https://www.dovepress.com/encouraging-pathological-complete-response-rate-from-neoadjuvant-chemo-peer-reviewed-article-CMAR
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!